Discover the full directors' dealings record of NU Skin Enterprises, INC., a listed issuer based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, NU Skin Enterprises, INC. has logged 83 public disclosures. Market capitalisation: €297.1m. The latest transaction was reported on 23 June 2022 — Cession. Among the most active insiders: WOODBURY EDWINA D. The full history is accessible without an account.
25 of 83 declarations
Nu Skin Enterprises, Inc. (NYSE: NUS) is a U.S.-listed company on the New York Stock Exchange, headquartered in Provo, Utah, United States. Founded in 1984, the company grew out of a direct-selling model and has evolved into a global beauty and wellness platform that combines consumer brands, product innovation, and an affiliate-based distribution network. For investors, Nu Skin should be viewed as a specialized consumer-health and prestige-beauty franchise with exposure to anti-aging, preventive wellness, and social/digital commerce trends. ([nuskin.com](https://www.nuskin.com/in/en/site/company/about-us?utm_source=openai))\n\nThe business is organized around two principal product categories: beauty and wellness. Under the Nu Skin brand, the company sells skincare, personal care, and beauty device systems. Under Pharmanex, it offers nutritional supplements and wellness-oriented products. The ageLOC franchise is a core differentiator, spanning anti-aging skincare, connected beauty devices, and products positioned around healthy aging. Nu Skin emphasizes more than 40 years of scientific research, clinical substantiation, and innovation as part of its premium brand positioning and distributor appeal. ([ir.nuskin.com](https://ir.nuskin.com/news-releases/news-release-details/nu-skin-enterprises-announce-fourth-quarter-and-full-year-2025?utm_source=openai))\n\nNu Skin operates in nearly 50 markets worldwide, giving it a broad geographic footprint across Asia-Pacific, the Americas, Europe, and other international regions. That global reach supports revenue diversification and brand visibility, but it also introduces foreign-exchange volatility, local regulatory complexity, and uneven consumer demand across regions. In 2025, revenue was primarily generated by the beauty and wellness categories, while the Rhyz ecosystem contributed additional income through adjacent consumer, technology, and manufacturing activities. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1021561/000114036126013156/ef20069502_ars.pdf?utm_source=openai))\n\nFrom a competitive standpoint, Nu Skin operates in a crowded landscape that includes multinational cosmetics groups, direct-selling peers, and digitally native consumer brands. Its competitive advantages lie in its long operating history, international affiliate base, premium product portfolio, and recurring product-launch cadence. Recent company disclosures show that fiscal 2025 results came in within guidance, and the company’s initial fiscal 2026 outlook points to a return to revenue growth by year-end. Recent notable initiatives include the launch of Prysm iO and continued expansion of ageLOC lines, signaling an ongoing effort to reignite organic growth and strengthen customer and affiliate retention. ([ir.nuskin.com](https://ir.nuskin.com/news-releases/news-release-details/nu-skin-enterprises-reports-fourth-quarter-and-full-year-2025?utm_source=openai))